• About
  • Contact
Money Works Magazine
  • Life Sciences
  • Real Estate
  • Personal Finance
Money Works Magazine
  • Life Sciences
  • Real Estate
  • Personal Finance
Money Works Magazine
Home Business

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Expands Contract for PCR Testing Equipment

Money Works Magazine by Money Works Magazine
September 22, 2020
in Business
0
“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Expands Contract for PCR Testing Equipment
Share on FacebookShare on Twitter

[ad_1]

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million.”

Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has rapidly expanded its agreement with a Wisconsin-based laboratory to supply it with the necessary testing equipment and supplies to ramp up to 12,000 tests a day, for a total contract value of $47.5 million in reagent sales by Todos Medical over the next seven months. Todos will be supplying automated extraction machines, liquid handlers and PCR machines. Todos has also been granted a priority right to supply the lab with up to 100,000 COVID PCR tests per day in the event the laboratory sees significant additional testing demand.

Headquartered in Rehovot, Israel, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer’s influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos’ two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe. Todos recently entered into an exclusive option agreement to acquire U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab and Provista’s proprietary commercial-stage Videssa® breast cancer blood test. The transaction is expected to close in the third quarter of 2020.

For more information, please visit: Todos Medical Ltd

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

[ad_2]
Written by financial buzz.
View the original article at here.
Financial Buzz
www.financialbuzz.com

Recommended

Zuora Earnings: ZUO Stock Plunges on Downside Q2 Guidance

Zuora Earnings: ZUO Stock Plunges on Downside Q2 Guidance

2 years ago
Japanese Live Entertainment Company, SCRAP, Enters China Market with Real-life Immersive NARUTO Game Collaboration

Health Monitors see 182% Growth due to Infectious Nature of COVID-19 – ResearchAndMarkets.com

12 months ago

MWM is your friendly source of knowledge on financial freedom and planning to make your money work for you.

  • Home
  • Life Sciences
  • Personal Finance
  • Online Gaming
  • Mining
  • Technology

© 2019 Money Works Magazine . All rights reserved.